IP Verse

Merz Pharma competitive analysis

Loading summary...

Latest oppositions filed by Merz Pharma

Explore patent oppositions filed by Merz Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3796929
Suppression Of Bone Cancer-Induced AllodyniaIPSEN BIOPHARMJun 18, 2025
EP3509559
Injectable Gels Comprising Cross-Linked Hyaluronic Acid And Hydroxyapatite, And Methods Of Manufacturing ThereofALLERGAN PHARMACEUTICALSMar 7, 2024
EP3256097
Compositions And Methods For Improving Skin AppearanceALLERGAN INDUSTRIEOct 5, 2022
EP2649101
Process Of Preparing A Cross Linked GelTEOXANEMar 2, 2022
EP3279335
Highly Sensitive Cell-Based Assay To Detect The Presence Of Active Botulinum Neurotoxin Serotype-AABELDec 8, 2021
EP3138586
Soft Tissue FillerALLERGAN INDUSTRIEOct 6, 2021
EP3270951
Botulinum Neurotoxin-Specific Capture Agents, Compositions, And Methods Of Using And MakingCALIFORNIA INSTITUTE OF TECHNOLOGYJun 9, 2021
EP3270162
Botulinum Toxin Assay With Improved SensitivityBIOMADISONMar 30, 2021
EP3187219
Injection DeviceALLERGANJan 22, 2021
EP2674147
Hyaluronic Acid-Based Gels Including Anesthetic AgentsALLERGAN INDUSTRIESep 30, 2020

Latest patents of Merz Pharma opposed by its competitors

Explore Merz Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4161562
Nov 20, 2024High Dose And Low Volume Botulinum Toxin Treatment Of Facial Wrinkles1
EP3236939
Aug 28, 2024Botulinum Toxin Prefilled Container1
EP3125961
Jul 31, 2019Polysaccharide Soft Tissue Fillers With Improved Persistence1
EP2836196
Jun 12, 2019Preparation For Topical Application To Mucosa Containing Polyhexanide As Active Ingredient1
EP2627318
Aug 16, 2017Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian Excipients1
EP2723319
Mar 29, 2017Composition Comprising An Onion Extract And Liposomes1

Latest publications and patents of Merz Pharma New

Explore the latest publications and patents granted to Merz Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merz Pharma

EP4161562
Nov 20, 2024High Dose And Low Volume Botulinum Toxin Treatment Of Facial WrinklesGranted And Under Opposition
EP3236939
Aug 28, 2024Botulinum Toxin Prefilled ContainerPatent Maintained As Amended
EP3125961
Jul 31, 2019Polysaccharide Soft Tissue Fillers With Improved PersistenceOpposition Rejected
EP2836196
Jun 12, 2019Preparation For Topical Application To Mucosa Containing Polyhexanide As Active IngredientRevoked
EP2627318
Aug 16, 2017Formulation Suitable For Stabilizing Proteins, Which Is Free Of Mammalian ExcipientsOpposition Rejected
EP2723319
Mar 29, 2017Composition Comprising An Onion Extract And LiposomesOpposition Rejected

Latest PTAB cases involving Merz Pharma

Discover the latest PTAB cases involving Merz Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Merz Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERZ PHARMA176 - -
ALLERGAN11291333
ALLERGAN INDUSTRIE - 11 - 10
BIOMADISON - 3 - -